ORAMED PHARMACEUTICALS INC (ORMP) Stock Income Statement
NASDAQ:ORMP - Nasdaq - US68403P2039 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.00M | 0.00 | 1.34M | 2.70M | 2.70M | |||
| Minority Interest Expense | 41.00K | 43.00K | 437.00K | 1.20M | 750.00K | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | 904.00K | |||
| Operating Expenses | 14.33M | 12.78M | 17.11M | 43.30M | 26.93M | |||
| Research and Development | 7.35M | 6.32M | 8.97M | 27.64M | 20.99M | |||
| Selling, General, and Administrative Expenses | 6.98M | 6.46M | 8.43M | 15.66M | 5.94M | |||
| Operating Income | -14.32M | -12.78M | -15.77M | -40.60M | -24.22M | |||
| Interest Income/Expense | -10.19M | -4.14M | 22.26M | 2.77M | 1.24M | |||
| Other Income/Expense | N/A | 1.00M | -1.40M | 170.00K | -10.00K | |||
| Income Before Taxes | -24.51M | -15.92M | 5.09M | -37.66M | -22.99M | |||
| Income Tax | 3.77M | 3.18M | 0.00 | 100.00K | 0.00 | |||
| Net Income | -28.24M | -19.06M | 5.53M | -36.56M | -22.24M | |||
| EBITDA | -14.15M | -12.59M | -15.57M | -40.54M | -24.14M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.69 | -0.47 | 0.14 | -0.94 | -0.78 | |||
| Non GAAP EPS | N/A | -0.18 | 0.14 | -0.94 | -0.78 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | 33.48% | |||
| Profit Margin | -1411.90% | N/A | 412.31% | -1354.07% | -823.70% | |||
| Operating Profit Margin | -715.95% | N/A | -1176.79% | -1503.70% | -897.04% | |||
All data in USD